Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Lu, Ph.D.


This page shows the publications co-authored by Christine Lu and Ann Wu.
Connection Strength

  1. Modeling Genomic Screening in Newborns. JAMA Pediatr. 2022 Apr 01; 176(4):344-346.
    View in: PubMed
    Score: 0.995
  2. Ending the Diagnostic Odyssey-Is Whole-Genome Sequencing the Answer? JAMA Pediatr. 2020 09 01; 174(9):821-822.
    View in: PubMed
    Score: 0.892
  3. The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies. J Pers Med. 2018 Oct 01; 8(4).
    View in: PubMed
    Score: 0.781
  4. Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer. J Pers Med. 2018 May 16; 8(2).
    View in: PubMed
    Score: 0.761
  5. Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients. J Pers Med. 2017 Nov 15; 7(4).
    View in: PubMed
    Score: 0.735
  6. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights. Genet Med. 2021 07; 23(7):1366-1371.
    View in: PubMed
    Score: 0.232
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.